Intended for UK Healthcare Professionals. Prescribing Information and Adverse Events reporting can be accessed in the footer of the site.

Migraine Space

Understanding the burden of migraine on the NHS

Bethany Hill and Elizabeth Akinsanya discuss how migraine prevention can ease NHS pressure and improve outcomes

Head Start 2025 Webinar

Bethany Hill, Senior Headache Specialist Nurse, and Elizabeth Akinsanya, Advanced Neuroscience Pharmacist, explore the real cost of migraine for patients, the NHS and wider society.

They explore how early intervention, PROMs and shared decision making can help optimise migraine management. Diving into real-world data, they also discuss how AJOVY® (fremanezumab) preventive therapy has been shown to ease NHS pressures and reduce migraine days in patients.¹

Resources

Education & Events Featured

Sleep Disorders and Headache

Dr Alexander Nesbitt provides an overview of sleep-related headache disorders

Education & Events

Behavioural change for migraine prevention

Professor Ivo Vlaev discusses the application of behavioural science in migraine prevention

Education & Events

Cracking complex cases: complexities of comorbidities in headache

Complexities of comorbidities in headache with Dr David Moreno and Dr Maria Villar-Martinez

Education & Events

Practical management of migraine and comorbid depression and anxiety

Dr Sophie White and Elizabeth Shaw share real-world strategies to help you manage migraine patients with depression and anxiety.

Education & Events

Care closer to home – headache service redesign to bring care into the community

Anne-Marie Logan discusses headache service redesign to bring care into the community

Education & Events

Managing migraine patients’ unmet need today

Susie Lagrata and Claire Fisher deliver a nurse-led masterclass on unmet needs in migraine care

Education & Events

Migraine anxiety & depression cycle: CGRP inhibitors help break it?

Dr Giorgio Lambru discusses migraine anxiety and depression cycle

References:

1. Afridi S, et al. Real-world reductions in monthly migraine days and migraine-related health care resource utilization in UK patients with migraine who initiated fremanezumab treatment. Poster presented at MTIS 2022. MTIS22-PO-031; 8-11 September 2022; London, United Kingdom

Abbreviations:

PROM, patient-reported outcome measures
NHS, national health service

Date of Preparation: December 2025 | D: MIG-GB-00924 / T: MIG-GB-00984 / M: MIG-GB-00985
Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX